Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Tang

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
International Journal of Cancer|May 8, 1993
Phenotypic properties of cultured tumor cells: integrin alpha IIb beta 3 expression, tumor-cell-induced platelet aggregation, and tumor-cell adhesion to endothelium as important parameters of experimental metastasisD G Tang, J M Onoda, B W Steinert, et al.
Anticancer Research|May 5, 1999
A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. II: In vivo efficacy and pharmacokinetic studiesL Li, Z Zhu, B Joshi, et al.
Oncogene|February 2, 2006
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cellsL Patrawala, T Calhoun, R Schneider-Broussard, et al.
The Prostate|February 11, 1999
Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosisS V Garde, V S Basrur, L Li, et al.
Oncogene|June 2, 2010
Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescenceM V Suraneni, R Schneider-Broussard, J R Moore, et al.
Journal of Biomolecular Techniques : JBT|March 13, 2023
Commercial ChIP-Seq Library Preparation Kits Performed Differently for Different Classes of Protein TargetsM S Simper, L Della Coletta, S Gaddis, et al.
Pathology Oncology Research : POR|October 8, 1998
BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteasesD G Tang, L Li, Z Zhu, et al.
Annals of Surgery|September 24, 1999
Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resectionJ W Harmon, D G Tang, T A Gordon, et al.
Pathology Oncology Research : POR|March 1, 1996
Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterationsK V Honn, A Aref, Y Q Chen, et al.
Oncogene|January 26, 2016
Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell propertiesA N Paranjape, R Soundararajan, S J Werden, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
International Journal of Cancer|May 8, 1993
Phenotypic properties of cultured tumor cells: integrin alpha IIb beta 3 expression, tumor-cell-induced platelet aggregation, and tumor-cell adhesion to endothelium as important parameters of experimental metastasisD G Tang, J M Onoda, B W Steinert, et al.
Anticancer Research|May 5, 1999
A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. II: In vivo efficacy and pharmacokinetic studiesL Li, Z Zhu, B Joshi, et al.
Oncogene|February 2, 2006
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cellsL Patrawala, T Calhoun, R Schneider-Broussard, et al.
The Prostate|February 11, 1999
Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosisS V Garde, V S Basrur, L Li, et al.
Oncogene|June 2, 2010
Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescenceM V Suraneni, R Schneider-Broussard, J R Moore, et al.
Journal of Biomolecular Techniques : JBT|March 13, 2023
Commercial ChIP-Seq Library Preparation Kits Performed Differently for Different Classes of Protein TargetsM S Simper, L Della Coletta, S Gaddis, et al.
Pathology Oncology Research : POR|October 8, 1998
BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteasesD G Tang, L Li, Z Zhu, et al.
Annals of Surgery|September 24, 1999
Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resectionJ W Harmon, D G Tang, T A Gordon, et al.
Pathology Oncology Research : POR|March 1, 1996
Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterationsK V Honn, A Aref, Y Q Chen, et al.
Oncogene|January 26, 2016
Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell propertiesA N Paranjape, R Soundararajan, S J Werden, et al.
Pageof 6